# Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study

Study · id `cardio:ct-nct03398096` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03398096](<https://clinicaltrials.gov/study/NCT03398096>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03398096

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT03398096. Randomized; single masking; primary purpose treatment. Start 2018-03-30 (anticipated); primary completion 2018-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT03398096, source copy `cardio:ctgov-nct03398096-2018-01-12`, retrieved 2026-10-26)
- Planned start: 2018-03-30 (anticipated) (ClinicalTrials.gov record NCT03398096, source copy `cardio:ctgov-nct03398096-2018-01-12`, retrieved 2026-10-26)
- Primary completion: 2018-06-30 (anticipated) (ClinicalTrials.gov record NCT03398096, source copy `cardio:ctgov-nct03398096-2018-01-12`, retrieved 2026-10-26)
- Completion: 2018-09-30 (anticipated) (ClinicalTrials.gov record NCT03398096, source copy `cardio:ctgov-nct03398096-2018-01-12`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03398096, source copy `cardio:ctgov-nct03398096-2018-01-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03398096-2018-01-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Improvement of Cardiac Function in Patients With Ischemic Cardiomyopathy by Extracorporeal Shock Wave Therapy: a Multicenter Clinical Study
- Condition: Coronary Artery Disease
- Intervention (Device): Cardiac shock wave therapy
- Lead sponsor: Shanghai 10th People's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Shanghai 10th People's Hospital (`cardio:org-shanghai-10th-people-s-hospital`)

## Provenance

Content hash: 8030c84821fc888a263fb43f6e9b3945204703089385bd74e77c3eb287c3f6aa
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
